Table 1 Baseline clinical characteristics of the study population

From: Differences between daytime and nighttime blood pressure variability regarding systemic atherosclerotic change and renal function

 

Total

Number

120

Sex (male/female)

50/70

Age (years)

68.8±1.1

BMI (kg m−2)

23.8±0.4

Diabetes mellitus (n, %)

33 (30.8%)

Dyslipidemia (n, %)

43 (36.1%)

eGFR (ml min−1 per 1.73 m2)

61.3±2.0

24-h SBP (mm Hg)

132.0±1.6

24-h DBP (mm Hg)

77.8±1.1

Total cholesterol (mg dl−1)

194.2±3.2

Triglyceride (mg dl−1)

124.1±6.5

HDL cholesterol (mg dl−1)

55.7±1.6

LDL cholesterol (mg dl−1)

112.9±2.8

UA (mg dl−1)

5.9±0.1

HbA1c (%)

5.8±1.1

Antihypertensive agents (n, %)

61 (92.5%)

 ARB (n, %)

61 (50.8%)

 ACEI (n, %)

12 (10.0%)

 CCB (n, %)

89 (74.2%)

 Diuretic (n, %)

35 (29.2%)

 Beta blocker (n, %)

27 (22.5%)

 Alpha blocker (n, %)

16 (13.3%)

 Aldosterone blocker (n, %)

6 (5.0%)

  1. Values are expressed as mean±s.e.m. or numbers.
  2. Abbreviations: ABPM, ambulatory blood pressure monitoring; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BMI, body mass index; CCB, calcium channel blocker; eGFR, glomerular filtration rate; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; UA, uric acid; 24-h DBP, 24-h diastolic blood pressure (all-day, evaluated with ABPM); 24-h SBP, 24-h systolic blood pressure (all-day, evaluated with ABPM).
Back to article page